Live tape
Top 8, mentions 7d15,265NVDA6,540 mentions▲ +0.04GOOGL1,864 mentions▲ +0.04SPY1,671 mentions▲ +0.05QQQ1,446 mentions▲ +0.05SPCX1,139 mentions▲ +0.06AMD950 mentions▲ +0.08MSFT842 mentions▲ +0.03CRWV813 mentions▲ +0.07

Equity · Healthcare

KRRO

NASDAQ

Korro Bio (KRRO)

12.26 USD −0.08% vs prior close
Korro Bio, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
168.3M USD
Revenue, year to Dec 2025
6.4M USD
EPS, diluted, year to Dec 2025
−12.48 USD
Avg volume
44.2K

as of Jul 17, 2026

Have Korro Bio (KRRO) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, Korro Bio insiders reported 7 open-market sales and 3 purchases (SEC Form 4).

Form 4, 90 days to 11 Nov 2026, newest reported trade 26 Oct 2026

3buys
7sells
$304Knet sold
0other filings
Have Korro Bio (KRRO) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
26 Oct 2026Lynx1 Capital Management LP10% OwnerBuy25,124295K USD
23 Oct 2026Lynx1 Capital Management LP10% OwnerBuy2,51030K USD
22 Oct 2026Lynx1 Capital Management LP10% OwnerBuy52,175559K USD
14 Sep 2026FORMELA JEAN FRANCOISDirectorSell38,490543K USD
11 Sep 2026FORMELA JEAN FRANCOISDirectorSell10,200143K USD
11 Sep 2026Dolan OliverSenior Vice President, FinanceSell569 USD
09 Sep 2026Dolan OliverSenior Vice President, FinanceSell682 USD
08 Sep 2026Dolan OliverSenior Vice President, FinanceSell7,34799K USD
26 Aug 2026FORMELA JEAN FRANCOISDirectorSell3004K USD
19 Aug 2026FORMELA JEAN FRANCOISDirectorSell28,468399K USD
Bought3 open-market purchases79,809$885K
Sold7 open-market sales84,816$1.19M

Which funds hold Korro Bio (KRRO)?

8 of the 45 institutional funds we track reported a Korro Bio position for the quarter ended 30 Jun 2026 — a combined 23.1M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Korro Bio (KRRO)?
FundPositionSharesValueShares q/q
Balyasny Asset ManagementHeld (±25%)951,78312.5M USD−8.5%
AQR Capital ManagementHeld (±25%)298,9743.9M USD+11.7%
Two Sigma InvestmentsHeld (±25%)178,0712.3M USD+7.6%
Millennium ManagementAdded118,4341.6M USD+86.2%
Renaissance TechnologiesHeld (±25%)110,5241.5M USD−18.9%
Citadel AdvisorsAdded40,390532K USD+30.7%
D. E. Shaw & Co.New position34,213451K USD
Marshall WaceTrimmed19,060251K USD−44.5%

What has been filed or recorded for Korro Bio (KRRO)?

The filings we hold for Korro Bio, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Korro Bio (KRRO)?
And
14 Oct 2026Fails to deliverShares failed to deliver6,189 shares55K USD notional · 0.042% of shares out
13 Oct 2026Fails to deliverShares failed to deliver2,381 shares22K USD notional · 0.016% of shares out
07 Oct 2026Fails to deliverShares failed to deliver2,469 shares24K USD notional · 0.017% of shares out
06 Oct 2026Fails to deliverShares failed to deliver1,336 shares13K USD notional · 0.009% of shares out
01 Oct 2026Fails to deliverShares failed to deliver7,025 shares70K USD notional · 0.048% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.98 USD
30 Sep 2026FinancialsTotal assets148.1M USDat period end
30 Sep 2026FinancialsTotal equity incl. minority interest88.4M USDat period end
29 Sep 2026Fails to deliverShares failed to deliver1,110 shares11K USD notional · 0.008% of shares out
28 Sep 2026Fails to deliverShares failed to deliver10,049 shares96K USD notional · 0.068% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −1.07 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −1.69 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −12.48 USDRevenue $6M
31 Dec 2025FinancialsRevenue6.4M USDfiscal year
31 Dec 2025FinancialsNet income−117.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−12.48 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −1.92 USDRevenue $1M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −2.74 USDRevenue $1M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −2.49 USDRevenue $3M
31 Dec 2024Annual reportFY 2024 reportedEPS −9.37 USDRevenue $2M

What do people ask about Korro Bio (KRRO)?

From live data
What is Korro Bio’s market cap?168.3M

Korro Bio is worth 168.3M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is Korro Bio’s revenue?6.4M

Korro Bio reported revenue of 6.4M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Korro Bio insiders bought or sold shares recently?7 sales

In the 90 days to 11 Nov 2026, Korro Bio insiders reported 7 open-market sales and 3 purchases (SEC Form 4). See Insiders

Which funds own Korro Bio?8 of 45

8 of the 45 funds we track reported a Korro Bio position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Balyasny Asset Management, AQR Capital Management and Two Sigma Investments. See Funds

When did Korro Bio last report earnings?−0.98

Korro Bio last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.98 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings